سعر بروجراف 1مجم 100 كبسولة 2024
Prograf 1mg 100 caps- المادة الفعالة: Tacrolimus
- Hikma
- عن طريق الفم
الفئة: مثبط للمناعة
معلومات الدواء
التفاصيل الكاملةعن الدواءAbout the medicine
Tacrolimus 1 mg hard capsules (Prograf), calcineurin-inhibitor immunosuppressant used to prevent organ transplant rejection; pack of 100 capsules distributed in Egypt by Hikma.
Tacrolimus 1 mg hard capsules (Prograf), calcineurin-inhibitor immunosuppressant used to prevent organ transplant rejection; pack of 100 capsules distributed in Egypt by Hikma.
دواعي الاستعمالUses
- Prophylaxis of organ rejection in adult and pediatric recipients of allogeneic kidney, liver, heart or lung transplants, with other immunosuppressantsالفئة: Adults and pediatric patientsDailyMed (NLM)
- Prophylaxis of organ rejection in adult and pediatric recipients of allogeneic kidney, liver, heart or lung transplants, with other immunosuppressantsPopulation: Adults and pediatric patientsDailyMed (NLM)
الآثار الجانبيةSide effects
- Most common (>=15%): abnormal renal function, hypertension, diabetes mellitus, fever, CMV infection, tremor, hyperglycemia, leukopenia, infection, anemia, constipation, diarrhea, headache, abdominal pain.نشرة دولية لنفس التركيبة · DailyMed (NLM)
- Most common (>=15%): abnormal renal function, hypertension, diabetes mellitus, fever, CMV infection, tremor, hyperglycemia, leukopenia, infection, anemia, constipation, diarrhea, headache, abdominal pain.International label, same formulation · DailyMed (NLM)
موانع الاستعمالContraindications
- Hypersensitivity to tacrolimus (the injection is also contraindicated with hypersensitivity to polyoxyl 60 hydrogenated castor oil).نشرة دولية لنفس التركيبة · DailyMed (NLM)
- Hypersensitivity to tacrolimus (the injection is also contraindicated with hypersensitivity to polyoxyl 60 hydrogenated castor oil).International label, same formulation · DailyMed (NLM)
تحذيرات واحتياطاتWarnings & precautions
- Boxed warning: increased risk of serious infections and malignancies (including lymphoma) that may lead to hospitalization or death.نشرة دولية لنفس التركيبة · DailyMed (NLM)
- Not interchangeable with extended-release tacrolimus products; risk of medication errors. Other warnings: new-onset diabetes after transplant, nephrotoxicity, neurotoxicity including PRES, hyperkalemia, hypertension, QT prolongation, avoid live vaccines, pure red cell aplasia.نشرة دولية لنفس التركيبة · DailyMed (NLM)
- Boxed warning: increased risk of serious infections and malignancies (including lymphoma) that may lead to hospitalization or death.International label, same formulation · DailyMed (NLM)
- Not interchangeable with extended-release tacrolimus products; risk of medication errors. Other warnings: new-onset diabetes after transplant, nephrotoxicity, neurotoxicity including PRES, hyperkalemia, hypertension, QT prolongation, avoid live vaccines, pure red cell aplasia.International label, same formulation · DailyMed (NLM)
التداخلات الدوائيةDrug interactions
- Strong CYP3A inhibitors (e.g. nelfinavir) and grapefruit juiceIncrease tacrolimus concentrations; avoid or monitor trough levels and adjust dose.DailyMed (NLM)
- CYP3A4 inducersDecrease tacrolimus concentrations; monitor and adjust dose.DailyMed (NLM)
- Mycophenolic acid productsHigher MPA exposure than with cyclosporine; monitor MPA-related adverse reactions.DailyMed (NLM)
- Strong CYP3A inhibitors (e.g. nelfinavir) and grapefruit juiceIncrease tacrolimus concentrations; avoid or monitor trough levels and adjust dose.DailyMed (NLM)
- CYP3A4 inducersDecrease tacrolimus concentrations; monitor and adjust dose.DailyMed (NLM)
- Mycophenolic acid productsHigher MPA exposure than with cyclosporine; monitor MPA-related adverse reactions.DailyMed (NLM)
الحمل والرضاعةPregnancy & breastfeeding
- Tacrolimus can cause fetal harm; in-utero exposure has been associated with prematurity, birth defects, low birth weight and fetal distress. A transplant pregnancy registry exists.نشرة دولية لنفس التركيبة · DailyMed (NLM)
- Tacrolimus has been reported in human milk; weigh benefits of breastfeeding against maternal need and potential infant effects.نشرة دولية لنفس التركيبة · DailyMed (NLM)
- Tacrolimus can cause fetal harm; in-utero exposure has been associated with prematurity, birth defects, low birth weight and fetal distress. A transplant pregnancy registry exists.International label, same formulation · DailyMed (NLM)
- Tacrolimus has been reported in human milk; weigh benefits of breastfeeding against maternal need and potential infant effects.International label, same formulation · DailyMed (NLM)
كيف يعمل الدواءHow it works
- Binds FKBP-12; the complex inhibits calcineurin, suppressing T-cell activation and interleukin-2 transcription.
- Tacrolimus: Binds FKBP-12; the complex inhibits calcineurin, suppressing T-cell activation and interleukin-2 transcription.
تاريخ السعر
تغيّر السعر الرسمي: من 2,732 إلى 3,552 ج.م، 2 أسعار مسجلة
| التاريخ | السعر (ج.م) |
|---|---|
| سعر سابق بدون تاريخ | 2,732 |
| 3,552 |
| التاريخ | من | إلى | التغيير |
|---|---|---|---|
| 2,732ج.م | 3,552ج.م | زيادة 30% |
المعرّفات
- مراجع علمية للمادة الفعالة
- TacrolimusPubChem (يفتح في نافذة جديدة)
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Hikma
من فئة مثبط للمناعة
- امجيفيتا 40مجم/0.8مل 2 قلم معبأ للحقنمحلول للحقن في قلم مملوء مسبقًا11,680ج.م
- امجيفيتا 40 مجم 0.8 مل 2 سرنجةمحلول للحقن في محقنة مملوءة مسبقًا11,680ج.م
- انابراميون 75 مجم 10 اقراصأقراص9ج.م
- اندوماتويد 2مجم 28 قرصأقراص مغلفة1,100ج.م
- اندوماتويد 4مجم 28 قرصأقراص مغلفة2,200ج.م
- اربيمون ام اي 25 مجم 50 كبسولةكبسولات جيلاتينية رخوة (مستحلب دقيق)218ج.م
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (NLM)
- PubChem
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا